Neither Metabolic Dysfunction Associated Steatotic Liver Disease Presence Nor Fibrosis Severity, By FIB4, Predicts Adverse Pregnancy Outcomes
Neither MASLD nor fibrosis severity, by FIB-4 score, independently influences maternal and fetal outcomes. The adverse outcomes likely reflect extrahepatic components of metabolic syndrome.
Authors
- Janese Thompson
- Suzanne R. Sharpton (ORCID: https://orcid.org/0000-0001-7722-5716)
- Hillary Duckham
- Rolanda Lister
- Manhal J. Izzy (ORCID: https://orcid.org/0000-0002-6402-5333)
- Zoe Finer
- Christopher J Lindsell
- Yue Gao
- Christine Lopez
Institutions
- Duke University (US)
- Vanderbilt University (US)
- The University of Texas Southwestern Medical Center (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Journal of Clinical Gastroenterology
- Published
- 2026-01-05
- DOI
- https://doi.org/10.1097/mcg.0000000000002322
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00